Color science is the scientific study of color including lighting and optics; measurement of light and color; the physiology, psychophysics, and modeling of color vision; and color reproduction. It is the modern extension of traditional color theory.
Vision science is the scientific study of visual perception. Researchers in vision science can be called vision scientists, especially if their research spans some of the science's many disciplines.
Investigative Ophthalmology & Visual Science (IOVS) is an online journal published by the Association for Research in Vision and Ophthalmology (ARVO).
Stanley A. Klein is an American psychophysicist. He is Professor of Vision Science and Optometry at the University of California, Berkeley and a member of the Berkeley Visual Processing Laboratory. He was a consulting editor for Attention, Perception, & Psychophysics, a publication of the Psychonomic Society which promotes the communication of scientific research in psychology and allied sciences. His major area of research has been neurotechnology, a field of science that studies the body and mind through the nervous system by electronics and mechanisms. He was the co-chair for the SPIE meetings on human vision. Klein has authored and co-authored numerous papers on visual perception in the human brain. He is currently interested in the intersection of religion and science.
Mildred Mosler Weisenfeld is the Brooklyn-born founder of national not-for-profit foundation the National Council to Combat Blindness in 1946, now known as Fight for Sight, an organization based in New York City that provides initial funds to promising scientists early in their careers. For 50 years, Weisenfeld was a one-woman campaign to increase funding for eye research, despite losing her own vision and having no scientific training.
Julia A. Haller is an American ophthalmologist who is a Professor and Chair of the Department of Ophthalmology at Sidney Kimmel Medical College at Thomas Jefferson University. She also holds the William Tasman, M.D. Endowed Chair at Wills Eye Hospital in Philadelphia, where she is Ophthalmologist-in-Chief.
The Association for Ocular Pharmacology and Therapeutics (AOPT) is an organization that welcomes members from disciplines related to ocular pharmacology and its therapeutic applications. The mission of AOPT is the sustenance of a scientific network aiming the dissemination of knowledge in the field of ocular disease, pharmacology and therapeutics.
Joel S. Schuman, MD, FACS is Professor of Ophthalmology, the Kenneth L. Roper Endowed Chair, Vice Chair for Research Innovation, co-director of the Glaucoma Service at Wills Eye Hospital, Professor of Biomedical Engineering at Drexel University School of Biomedical Engineering, Science and Health Systems, Collaborative Community of Ophthalmic Imaging (CCOI) president, and American Glaucoma Society (AGS) Foundation advisory board chair. Prior to this he was the Elaine Langone Professor and Vice Chair for Research in the Department of Ophthalmology at NYU Langone Medical Center, NYU Grossman School of Medicine; Professor of Biomedical Engineering and Electrical & Computer Engineering at NYU Tandon School of Engineering and Professor of Neural Science in the Center for Neural Science at NYU College of Arts and Sciences. He chaired the ophthalmology department at NYU Langone Health, NYU Grossman School of Medicine 2016–2020, and was Vice Chair for Ophthalmology Research in the department 2020–2022. Prior to arriving at NYU in 2016, he was Distinguished Professor and Chairman of Ophthalmology, Eye and Ear Foundation Endowed Chair in Ophthalmology, Director of UPMC Eye Center (2003-2016) and before that was at Tufts University 1991–2003, where he was Residency Director (1991-1999) and Glaucoma and Cataract Service Chief (1991-2003). In 1998 he became Professor of Ophthalmology, and Vice Chair in 2001.
Reza Dana is the Claes H. Dohlman Professor of Ophthalmology, senior scientist and W. Clement Stone Clinical Research Scholar at Massachusetts Eye and Ear, Harvard Medical School, and director of the Harvard-Vision Clinical Scientist Development Program.
Filippo Drago is an Italian pharmacologist, neurologist and psychiatrist.
Joan Whitten Miller is a Canadian-American ophthalmologist and scientist who has made notable contributions to the treatment and understanding of eye disorders. She is credited for developing photodynamic therapy (PDT) with verteporfin (Visudyne), the first pharmacologic therapy for retinal disease. She also co-discovered the role of vascular endothelial growth factor (VEGF) in eye disease and demonstrated the therapeutic potential of VEGF inhibitors, forming the scientific basis of anti-VEGF therapy for age-related macular degeneration (AMD), diabetic retinopathy, and related conditions.
John E. Dowling is an American neuroscientist and Gordon and Llura Gund Research Professor of Neurosciences at Harvard University. He is best known for his seminal work in vision science, having elucidated the biochemistry of rhodopsin and development of the vertebrate retina, as well as diseases that affect vision such as vitamin A deficiency and retinitis pigmentosa. He was elected to the American Academy of Arts and Sciences in 1972, the National Academy of Sciences in 1976, and the American Philosophical Society in 1992.
Dean Evan Hart, O.D., M.A., M.S., B.S., A.A.S., F.A.A.O. is an American scientist, clinical optometrist, professor, and the founder of Woodbury Ophthalmic Group and Woodbury Optical Studio. Dean ran for Nassau County Legislature in 2015. He was a candidate for the New York State Assembly in the 15th Assembly District of the 2016 election. Hart also ran for town office in 2017.
Pablo Artal is a Spanish physicist and full professor specialized in optics at the University of Murcia, as well as in the development and application of new techniques in human vision research. He is the founder and director of the Optics Lab at Murcia University and received the Spanish National Research award "Juan de la Cierva" and the Rey Jaime I Award for New Technologies in 2015. His main research topics are the optics of the eye and the retina and the development of optical and electronic imaging techniques in the field of biomedicine, ophtalmology and vision. He has contributed to the advance of methods for the study of the optics of the eye and contributed to the understanding of the factors that limit the resolution of the human vision. Moreover, his discoveries and ideas have been applied to instruments and devices used in the clinical practice of ophthalmology.
Patricia Ann D'Amore is a professor at Harvard Medical School, where she is the Charles L. Schepens Professor of Ophthalmology, and Professor of Pathology.
Dimitri Azar is an American ophthalmologist, professor, and businessman who leads Twenty Twenty Therapeutics, a joint venture established by Santen and Verily. Azar has held roles at Novartis and Verily, Alphabet's Life sciences research organization. He served as dean of the College of Medicine at the University of Illinois at Chicago (UIC) from 2011 to 2018.
Steven J. Fliesler is a distinguished American biochemist and researcher renowned for his contributions to the field of ophthalmology. He currently holds the title of SUNY Distinguished Professor and serves as the Meyer H. Riwchun Endowed Chair Professor of Ophthalmology at the University at Buffalo, The State University of New York (SUNY). Additionally, he also serves as the Vice-Chair for Research in the Department of Ophthalmology and acts as the Director of the Ira G. Ross Eye Institute Vision Research Center at the Buffalo VA Medical Center, VA Western NY Healthcare System (VAWNYHS), in Buffalo, NY.
Sarah Coupland is an Australian-born pathologist and professor who is the George Holt Chair in Pathology at the University of Liverpool. Coupland is an active clinical scientist whose research focuses on the molecular genetics of cancers, with particular interests in uveal melanoma, conjunctival melanoma, intraocular and ocular adnexal lymphomas and CNS lymphoma. Coupland is also an NHS Honorary Consultant Histopathologist at the Royal Liverpool University Hospital. Since 2006, Coupland has been head of the Liverpool Ocular Oncology Research Group; from which she runs a multidisciplinary oncology research group focussing on Uveal melanoma, based in the Department of Molecular and Clinical Cancer Medicine at the University of Liverpool. Her research laboratory is currently located in the Institute of Translational Medicine From April 2014 to December 2019, Coupland was also Director of the North West Cancer Research Centre, @UoL. In both 2019 and 2020, Coupland was included on the 'Pathology Powerlist' on The Pathologist website.
Alon Harris is an American clinical scientist, professor of ophthalmology and Professor of Artificial Intelligence and Human Health, educator, inventor and researcher in the field of ocular blood flow and its relationship to diseases of the eye. Harris served as the principal or co-principal investigator on more than 60 research grants, published more than 392 peer-reviewed articles, and wrote 23 books and 70 book chapters. As of 2021, he holds two patents. Harris sits on the board of directors and the Scientific Advisory Board of The Glaucoma Foundation and is the Vice Chair of International Research and Academic Affairs, co-director of the Center for Ophthalmic Artificial Intelligence and Human Health at Mount Sinai Hospital, and Director of the Ophthalmic Vascular Diagnostic and Research Program at Icahn School of Medicine at Mount Sinai.
Alfredo Arrigo Sadun is an American ophthalmologist, academic, author and researcher. He holds the Flora L. Thornton Endowed Chair at Doheny Eye Centers-UCLA and is Vice-Chair of Ophthalmology at UCLA.
